Evidence map›Paper›PMID 41061230›Full record

ArticleJMIR medical informatics2025

Organizing Telemonitoring-Decision-Making Between Centralized and Distributed Models in the Netherlands, Using the Non-Adoption, Abandonment, Scale-Up, Spread, and Sustainability (NASSS) Framework: Case Study.

Nienke Antine Elferink, Manon Jacqueline Roest, Anne Marie Weggelaar, Marleen de Mul

Abstract read
In one paragraph

Article in JMIR medical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nienke Antine Elferink *Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, Rotterdam, 3062 PA, The Netherlands, 31 104081868.ORCID 0009-0001-4551-967X
Manon Jacqueline Roest *Tranzo, Tilburg University, Tilburg, The Netherlands.ORCID 0000-0002-5697-8548
Anne Marie WeggelaarTranzo, Tilburg University, Tilburg, The Netherlands.ORCID 0000-0002-7786-6326
Marleen de MulErasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, Rotterdam, 3062 PA, The Netherlands, 31 104081868.ORCID 0000-0003-3447-5920

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Telemonitoring can be implemented using either centralized or distributed organizational models. However, few published studies explore which conditions make one model preferable over the other, or how to choose between these two. Objective: This study aimed to investigate the decision-making factors across several domains (eg, technological, personal, and organizational) when selecting the telemonitoring model. Methods: We conducted a multiple case study across 4 purposively sampled hospitals to gain a range of perspectives on organizational models for telemonitoring. Selection criteria included: (1) type of organizational model, (2) type of collaborating partners, (3) task division of handling notifications, and (4) it had to be implemented at scale, rather than being in an exploratory phase. Data was collected in a document study, 13 semistructured interviews, and a focus group. The topic list was based on the domains of the NASSS (non-adoption, abandonment, scale-up, spread, and sustainability) framework. Interviewees (n=13) were 5 project leaders, 2 tele-nurses, 4 health care professionals, and 2 clinical informaticians. Data analysis was performed iteratively and included reflective thematic analysis. A member-checking focus group was organized to verify and reflect on the findings. Results: Various preferential factors based on the seven domains of the NASSS framework were explored for both centralized and distributed telemonitoring models: (1) Condition: the choice of objective, usually based on organizational strategy, determines whether telemonitoring will be centralized or distributed. (2) Technology: the preference for a model is determined by the anticipated number of notifications the application generates for a specific patient group. (3) Value proposition: the perceived cost-effectiveness and overall value to the patient shape the value proposition for each model. (4) Adopters: the new role of tele-nurse emerged in centralized monitoring centers (CMCs), necessitating new competencies, task redistribution, and shifts in responsibility. The importance of trust among staff became evident in the context of task redistribution. (5) Organization: CMCs are typically organized regionally, in partnerships or network arrangements, which can be time-consuming yet offer significant potential for impact. (6) Wider system: The existing Dutch reimbursement system does not incentivize CMCs because the payment structure is still based on a per-treatment model. (7) Adaptation over time: with advancements in technology, including artificial intelligence, organizing telemonitoring through CMCs is likely to gain popularity. Conclusions: Our study highlights that when decision makers are choosing which telemonitoring model-centralized or distributed-to implement in their organization, deciding on the suitability of the model depends on multiple contextual factors. Our findings illustrate that decisions made for patient group selection, technology design, and value proposition significantly influence each other. It is therefore crucial for decision makers to understand these interactions and corresponding dynamics to better align their strategies with the operational realities of their organization.

Indexed as

Decision MakingModels, OrganizationalTelemedicineFocus GroupsHumansNetherlandsOrganizational Case Studiescentralized telemonitoringdistributed telemonitoringNASSS frameworkqualitative studytelemonitoring

Identifiers

PMID41061230
PMCPMC12507340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.